Dr Nina Stewart
MBBS(Hons), FRANZCR, Radiation Oncologist
For patients/carers
For doctors
MBBS(Hons), FRANZCR, Radiation Oncologist
Locations
Clinical interests
- Breast cancer
- Metastatic cancer
- Gastrointestinal cancer
- Lung cancer
- Genitourinary cancer
- Lymphoma
- Brain and central nervous system
- Skin cancer
- Haematology
- Palliative medicine
Languages
Fluent
- English
Biography
Clinical interests in breast cancer, neuro-oncology, and palliative radiation therapy.
Nina completed her Bachelor of Medicine and Surgery at the University of Western Australia (UWA) with honours in 2008 and began her medical career at Fremantle Hospital, followed by community programs in the Kimberley and in palliative radiation therapy. She commenced specialist training in radiation oncology at Prince of Wales Hospital (NSW) in 2014.
This was followed by a clinical research fellowship in breast and central nervous system (CNS) tumours at Fiona Stanley Hospital, where Nina helped develop a treatment protocol to examine radiation therapy planning CT scans as a way to help estimate a patient's risk of potential future coronary artery disease.
Nina has been an examiner of medical students at UWA and UNSW and continues to lecture current radiation oncology trainees. She is also a member of the RANZCR palliative radiation therapy working group and is a board certified lifestyle medicine practitioner.
More information
Nina's clinical interests include breast cancer, neuro-oncology, palliative radiation therapy, stereotactic radiation therapy, value-based health care, patient experience, and outcome measures. She also has an interest in the benefits of integrative medicine.
- Royal Australian New Zealand College of Radiologists (RANZCR)
- American Society for Radiotherapy and Oncology (ASTRO)
- European Society for Radiotherapy and Oncology (ESTRO)
- Trans-Tasman Radiation Oncology Group (TROG)
- Society for Integrative Oncology (SIO)
- Australasian Society of Lifestyle Medicine (ASLM)
- Dalla Via, J., Stewart, N., Kennedy, M. A., Cehic, D. A., Purnell, P., Toohey, J., Morton, J., Ramchand, S. K., Lewis, J. R., & Zissiadis, Y. (2023). Protocol: Can coronary artery calcium score identified on thoracic planning CT scans be used and actioned to identify cancer survivors at high risk of cardiac events: A feasibility study in cancer survivors undergoing radiotherapy in Australia. BMJ Open, 13(7), e072376. https://doi.org/10.1136/bmjopen-2023-072376
- Dalla Via, J., Andrew, C. R., Baguley, B. J., Stewart, N., Hodgson, J. M., Lewis, J. R., ... & Kennedy, M. A. (2025). Breast and prostate cancer survivors’ understanding of risk and management of cardiovascular and musculoskeletal side effects of treatment: findings from focus groups. Supportive Care in Cancer, 33(7), 608.
- Ali, A., Dumbrava, M., Riddell, K., Stewart, N., Ward, R., Ibrahim, A. K., & Chin, M. (2020). Correlation between initial tumour volume and treatment duration on Dabrafenib: observation study of subjects with BRAF mutant melanoma on the BRF112680 trial. BMC cancer, 20(1), 342.
- Ebert, M. A., Foo, K., Haworth, A., Gulliford, S. L., Kearvell, R., Kennedy, A., Richardson, S., Krawiec, M., Stewart, N., Joseph, D. J., & Denham, J. W. (2014). Derivation and representation of dose–volume response from large clinical trial data sets: An example from the RADAR prostate radiotherapy trial. Journal of Physics: Conference Series, 489, 012090. https://doi.org/10.1088/1742-6596/489/1/012090
Explore more
Disclaimer:
This website is provided for information purposes only. Nothing on this website is intended to be used as medical advice, or to diagnose, treat, cure or prevent any disease. It should not be used as a substitute for your own health professional's advice. Any medical procedure or treatment carries risks. Before proceeding with treatment, you should discuss the risks and benefits of the treatment with an appropriately qualified health practitioner. Individual treatment outcomes and experiences will vary.